Effect of hyperbaric oxygen on the growth and susceptibility of facultatively anaerobic bacteria and bacteria with oxidative metabolism to selected antibiotics | Canada Hyperbarics Skip to main content
Study Folia Microbiol (Praha) 2024

Effect of hyperbaric oxygen on the growth and susceptibility of facultatively anaerobic bacteria and bacteria with oxidative metabolism to selected antibiotics

Chmelař D, Rozložník M, Hájek M, Pospíšilová N, Kuzma J — Folia Microbiol (Praha), 2024

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers tested whether high-pressure oxygen at 2.8 ATA changes how well common bacteria resist antibiotics, using a lab chamber to expose bacteria to hyperbaric conditions for 24 hours.

What They Found

For E. coli, Klebsiella pneumoniae, and Proteus mirabilis, hyperbaric oxygen did not meaningfully change the minimum antibiotic doses needed to kill them. However, Pseudomonas aeruginosa and related bacteria had their growth completely stopped under 2.8 ATA of 100% oxygen, and this growth suppression was reversible when pressure was removed.

What This Means for Canadian Patients

Patients receiving HBOT for wound infections do not need to worry that the treatment makes bacteria resistant to their antibiotics. The finding that hyperbaric oxygen completely stops Pseudomonas growth is especially relevant for patients with chronic wounds or ear infections caused by that bacteria, where HBOT may help antibiotics work more effectively.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This was a lab-only study using bacteria in broth, results in living human tissue may differ because of immune cells, blood flow, and other biological factors.

Was this summary helpful?

Study Details

Study Type Study
Category Infection
Source Pubmed
PubMed ID 38100018
Year Published 2024
Journal Folia Microbiol (Praha)
MeSH Terms Humans; Anti-Bacterial Agents; Hyperbaric Oxygenation; Bacteria, Anaerobic; Oxygen; Bacteria; Pseudomonas aeruginosa; Ampicillin; Escherichia coli; Trimethoprim, Sulfamethoxazole Drug Combination; Klebsiella pneumoniae; Pseudomonas Infections; Oxidative Stress; Microbial Sensitivity Tests; Sulbactam

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.